Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

Long-term treatment with Duvyzat (givinostat) may help delay the loss of walking ability and lessen the decline in lung ...

WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...

Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...

The United States market has remained flat over the past week but has seen an 8.5% increase over the past year, with earnings projected to grow by 14% annually. In this context, identifying ...